Sökning: onr:"swepub:oai:DiVA.org:kth-147051" >
CCL2 mediates anti-...
-
Kalderén, ChristinaKarolinska Institutet
(författare)
CCL2 mediates anti-fibrotic effects in human fibroblasts independently of CCR2
- Artikel/kapitelEngelska2014
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2014
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:kth-147051
-
https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-147051URI
-
https://doi.org/10.1016/j.intimp.2014.02.020DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:129043745URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
QC 20140624
-
CCL2 is known for its major role as a chemoattractant of monocytes for immunological surveillance and to site of inflammation. CCL2 acts mainly through the G-protein-coupled receptor CCR2 but has also been described to mediate its effects independently of this receptor in vitro and in vivo. Emerging pieces of evidence indicate that the CCL2/CCR2 axis is involved in fibrotic diseases, such as increased plasma levels of CCL2 and the presence of CCL2-hyperresponsive fibroblasts explanted from patients with systemic sclerosis and idiopathic pulmonary fibrosis. One of the profibrotic key mediators is the myofibroblast characterized by overexpression of alpha-smooth muscle actin and collagen I. However, the correlation between the CCL2/CCR2 axis and the activation of fibroblasts is not yet fully understood. We have screened human fibroblasts of various origins, human pulmonary fibroblasts (HPF), human fetal lung fibroblasts (HFL-1) and primary preadipocytes (SPF-1) in regard to CCL2 stimulated fibrotic responses. Surprisingly we found that CCL2 mediates anti-fibrotic effects independently of CCR2 in human fibroblasts of different origins.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Stadler, CharlotteKTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1r100ik
(författare)
-
Forsgren, Margareta
(författare)
-
Kvastad, LindaKTH,Genteknologi,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1fok912
(författare)
-
Johansson, ElinKTH,Genteknologi,Science for Life Laboratory, SciLifeLab(Swepub:kth)u151qhvp
(författare)
-
Sydow-Bäckman, Mona
(författare)
-
Gelius, Stefan Svensson
(författare)
-
Karolinska InstitutetProteomik och nanobioteknologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:International Immunopharmacology: Elsevier BV20:1, s. 66-731567-57691878-1705
Internetlänk
Hitta via bibliotek
Till lärosätets databas